Prognostic nomogram in patients with right-sided colon cancer after colectomy: a surveillance, epidemiology, and end results-based study
- PMID: 38549940
- PMCID: PMC10972961
- DOI: 10.3389/fonc.2024.1330344
Prognostic nomogram in patients with right-sided colon cancer after colectomy: a surveillance, epidemiology, and end results-based study
Abstract
Objective: This study aimed to develop and validate a nomogram for predicting overall survival (OS) in patients undergoing surgery for right-sided colon cancer (RCC).
Methods: We collected 25,203 patients with RCC from the Surveillance, Epidemiology, and End Results (SEER) database and randomly divided them into 7:3 training and internal validation set. Utilizing the Cox proportional hazards regression model, we constructed a nomogram based on prognostic risk factors. Furthermore, for external validation, we retrospectively followed up with 228 patients from Jiaxing First Hospital and assessed and calibrated the nomogram using the C-index and calibration curves.
Results: After identifying independent prognostic factors through univariate and multivariate analyses, a nomogram was developed. The c-index values of this nomogram differed as follows: 0.851 (95% CI: 0.845-0.857) in the training set, 0.860 (95% CI: 0.850-0.870) in the internal validation set, and 0.834 (95% CI: 0.780-0.888) in the external validation set, indicating the model's strong discriminative ability. Calibration curves for 1-year, 3-year, and 5-year overall survival (OS) probabilities exhibited a high level of consistency between predicted and actual survival rates. Furthermore, Decision Curve Analysis (DCA) demonstrated that the new model consistently outperformed the TNM staging system in terms of net benefit.
Conclusion: We developed and validated a survival prediction model for patients with RCC. This novel nomogram outperforms the traditional TNM staging system and can guide clinical practitioners in making optimal clinical decisions.
Keywords: SEER; nomogram; overall survival; prognosis; right-sided colon cancer.
Copyright © 2024 Qin, Yu, Dong, Zheng, Wang and Shen.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures








Similar articles
-
Development and validation of prognostic nomograms for early-onset colon cancer in different tumor locations: a population-based study.BMC Gastroenterol. 2023 Oct 21;23(1):362. doi: 10.1186/s12876-023-02991-1. BMC Gastroenterol. 2023. PMID: 37865754 Free PMC article.
-
Development and validation of a prognostic nomogram for early stage non-small cell lung cancer: a study based on the SEER database and a Chinese cohort.BMC Cancer. 2022 Sep 14;22(1):980. doi: 10.1186/s12885-022-10067-8. BMC Cancer. 2022. PMID: 36104656 Free PMC article.
-
Survival prognostic nomogram for young metastatic non-small cell lung cancer: a study of the US SEER database and a Chinese cohort.Front Oncol. 2025 Feb 14;15:1502253. doi: 10.3389/fonc.2025.1502253. eCollection 2025. Front Oncol. 2025. PMID: 40027127 Free PMC article.
-
Development and validation of a prognostic nomogram for breast cancer patients who underwent chemoradiotherapy and surgery: a retrospective cohort study based on the SEER database and two Chinese cohorts.Am J Cancer Res. 2023 Nov 15;13(11):5065-5081. eCollection 2023. Am J Cancer Res. 2023. PMID: 38058820 Free PMC article.
-
Development and validation of a dynamic survival nomogram for metastatic non-small cell lung cancer based on the SEER database and an external validation cohort.Transl Lung Cancer Res. 2022 Aug;11(8):1678-1691. doi: 10.21037/tlcr-22-544. Transl Lung Cancer Res. 2022. PMID: 36090634 Free PMC article.
References
-
- Cao M, Chen W. Interpretation of global cancer statistics from GLOBOCAN 2020. Chin J Front Med Sci (Electronic Edition). (2021) 13:7.
LinkOut - more resources
Full Text Sources